Cardiovascular and coronary risk estimation in hypertension management

Heart

Volumn 88, Issue 3, 2002, Pages 306-312

  Wallis, Erica J ^a   Ramsay, Lawrence E ^a   Jackson, Peter R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY RISK; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0036720350     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.3.306     Document Type: Review

References (20)

1. Cardiovascular disease risk profiles
2. The hypertension detection and follow-up program 17 years on
3. British Hypertension Society guidelines for hypertension management 1999: Summary
4. Joint British recommendations on prevention of coronary heart disease in clinical practice
5. Antihypertensive drug therapy: Effects on stroke and coronary heart disease
6. The potential effect of blood pressure reduction on cardiovascular disease
7. The number needed to treat: A clinically useful measure of treatment effect
8. An evidence based approach to individualising patient treatment
9. Does drug treatment improve survival? Reconciling the trials in mild to moderate hypertension
10. Mild hypertension: Treat patients, not populations
11. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?
12. Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population
13. Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention
14. Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation
15. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators
16. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
17. Guidelines for antihypertensive therapy: Problems with a strategy based on absolute cardiovascular risk
18. What is the optimal age for starting lipid lowering treatment? A mathematical model
19. Optimal age for starting lipid lowering treatment. Adjusted data do not justify a lower optimal age